Suppr超能文献

[98例慢性髓系白血病患者的死因、生存情况及预后因素]

[Cause of death, survival, and prognostic factors in a series of 98 patients with chronic myeloid leukemia].

作者信息

Jonte F, Fernández-Fuertes F, Cecchini C, Luño E, Ordóñez A, Fernández C, Suárez P, Lausín A, Fernández J

机构信息

Servicio de Hematología, Hospital Central de Asturias, Oviedo.

出版信息

Sangre (Barc). 1992 Oct;37(5):351-4.

PMID:1293774
Abstract

PURPOSE

To analyse the survival from diagnosis to blastic crisis, as well as the causes of death and the significance of different features in patients diagnosed of chronic myelogenous leukaemia (CML).

MATERIAL AND METHODS

The series includes 98 patients who died of CML in Asturias Central Hospital and other nearby hospital between 1970 and 1990. The CML diagnosis had been established according to conventional criteria. The blastic crisis was diagnosed in accordance with morphologic and cytochemical studies, complemented in some cases with the assay of TdT or other markers. The Kaplan-Meier curves and long-rank test were applied to the statistical analysis of survival. The prognostic factors were evaluated by univariate correlation.

RESULTS

The series' mean age was 48.57 years (range: 6-90) and the M/F ratio was 56/42. Cytogenetic study had been performed in 35 patients, of whom 33 had the Ph' chromosome. Death occurred in the blastic crisis in 67 cases (72%), in the accelerated phase in 14 cases (15%) and in the chronic phase in 12 cases (13%). The cause of death could be determined in 47 cases; of them, 24 (51%) died of infection, 11 (23.4%) of haemorrhage, and the remaining 12 (25.6%) of different complications. The median survival of the group as a whole was 32 months (range: 4-137). For the blastic crisis this figure was reduced to 2.5 months (range: 1-14), the lymphoid forms doing better, 5 months, than the non-lymphoid ones; 1.5 months (p < 0.03). Out of the data evaluated at diagnosis, only haemoglobin and the percentage of blast cells in peripheral blood showed any correlation with survival (r = +0.28, p < 0.05 for haemoglobin, and r = -0.30, p < 0.01 for blast cells).

CONCLUSIONS

(1) Although most patients die from infection or haemorrhage during the blast crisis, CML increases the risk of death in the accelerated and chronic stages as well. (2) Non-lymphoid blastic crisis has poorer prognosis than the lymphoid form. (3) The concentration of blast cells and haemoglobin in peripheral blood at diagnosis acquire prognostic significance in the present study.

摘要

目的

分析慢性粒细胞白血病(CML)患者从诊断到急变期的生存期、死亡原因以及不同特征的意义。

材料与方法

该系列包括1970年至1990年间在阿斯图里亚斯中心医院及附近其他医院死于CML的98例患者。CML诊断依据传统标准确立。急变期根据形态学和细胞化学研究诊断,部分病例辅以TdT或其他标志物检测。采用Kaplan-Meier曲线和长秩检验对生存期进行统计分析。通过单变量相关性评估预后因素。

结果

该系列患者平均年龄为48.57岁(范围:6 - 90岁),男女比例为56/42。35例患者进行了细胞遗传学研究,其中33例有Ph'染色体。67例(72%)死于急变期,14例(15%)死于加速期,12例(13%)死于慢性期。47例可确定死亡原因;其中,24例(51%)死于感染,11例(23.4%)死于出血,其余12例(25.6%)死于不同并发症。整个组的中位生存期为32个月(范围:4 - 137个月)。急变期该数字降至2.5个月(范围:1 - 14个月),淋巴细胞型表现较好,为5个月,而非淋巴细胞型为1.5个月(p < 0.03)。在诊断时评估的数据中,仅血红蛋白和外周血原始细胞百分比与生存期有相关性(血红蛋白r = +0.28,p < 0.05;原始细胞r = -0.30,p < 0.01)。

结论

(1)虽然大多数患者在急变期死于感染或出血,但CML在加速期和慢性期也会增加死亡风险。(2)非淋巴细胞型急变期预后比淋巴细胞型差。(3)在本研究中,诊断时外周血原始细胞浓度和血红蛋白具有预后意义。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验